yea r period from 1982 through 1984 were review ed. Those fo r whom maintenance ECT was used for at lea st six wee ks were select ed for st udy. Eight patients were so treated during this period. The cu r rent ( 198 7) sta tus of each patient and the intervening course of illness and treatment history were ascertained.
Sin ce treatment was not p rospectively sta ndard ized, but was ind ivid ually tailored to clinical course, th e fr equency and durati on of th e rapy varied . Fo r ease of review, the ca ses are ca te go r ized ac cording to th e treatme nt utilized and th e a pparent effectiveness of maintenance ECT. In addition to consideration o f the o verall course of illness, the rate of rehospitalizati on for d e pressio n in th e two yea rs subseq uen t to th e initiation o f maintenance ECT was compared with the two yea rs prior to initiation as a crude indication of effectiveness. By "effect ive ness" we mean th e nearl y total remission of affecti ve , melancholic, and ps ychotic sym p to m s. All psychiatric diagnoses were according to DSM-III critena.
ECT was performed in th e sta nd a rd manner for our ho spital with an eight hour fas t, intramuscular glycopyr rolate 30 m inutes prio r to trea tment, intravenous methohexital or e to rnid ate anesthesi a , a nd succ inylcholine muscle relaxation. Patients were carefull y monitored to insure th at a genera lized seizure of at lea st 30 second s duration had occurr ed. All were o u tpatients and were discharged when their vital signs were sta b le and t hey co uld safely leave with a relative or a fr ie nd .
S UMMARY OF CASES

Ma intenance ECT on a Continu ed Maintenance Basis
Case 1. Mr. A , a 7 3-year-old, ha s suffered recurrent e p isodes of melancho lic depression as part of a unipolar a ffec tive di so rde r fo r the past 26 years. Episodes were characteri zed by anhedonia, a norexia, agitat io n , a nd excruciating feelings of guilt and always responded to inpatient EC T. Lithium at 600 to 900 m g da ily for years (se rum le vel 0.5 to 0. 8 meq/I), trazodo ne 150 mg daily for two months in co nj u nct io n with lithium, 50 mg of amitryptylin e d ail y for two months (se r u m level 148 ng/ml), a n d d esipramine 150 m g d ail y for one yea r a ll failed to prev ent relapse. During th e two yea rs before mainten ance ECT was insti tuted, he was admitted six times for d epressive relapses, the freq uency of hosp ita lization having increased to approxim at el y e very t hree months. Mai nten a nce ECT was initiated after a successful co u rse of inpatient ECT. He has bee n admitted twic e for inpatient ECT du ring th e two yea rs since o u tpat ien t ECT was begun, with the r einstitution of ma intenance ECT upon di sch a rge . Bo th relapses occu r red wh en th e fr equency o f ECT had been red uced to every four weeks. Remission ha s now been susta ined for eigh t months with ECT every t hree weeks with no concu r ren t pharmacotherapy.
Maintenance EC T on a T empora ry Basis
JEFFE RSON JOU RNAL OF PSYCHI ATR Y Cas e 2. Mrs. B, a 65-yea r-old , has a 2 6 year h istory of recurrent melancholic d epression re q u ir ing mu lti ple h ospital izations d esp ite attempted maintenance with va r io us antidepressant medica tions including t razod o ne to 400 mg d ai ly for nin e weeks. In ad d itio n to stri king dysphor ia, symptoms included anorexi a, diurnal mood variatio n, a nd ps ych omo to r retardation. During th e two yea rs prior to initiation of mainten ance ECT , she was ho spita lized t hree times fo r d epression wh ich responded to in patient ECT, but relapse occurred despi te mainten an ce nortriptylin e 50 mg d aily for two mon ths, t hen one month at 100 mg d a ily. While r eceiving a co u rse of 18 ECT when last ho sp ital ized , sh e became h ypomanic and lithium th e rapy was instituted in consideration of possibl e bipolar rathe r than unipolar affective di sorder. Alo ng wit h ma in tenance lit h iu m 600 to 900 mg d ail y (seru m le vels of 0.6 to 1.0 meq /I), she received six weekl y outpatient ECT . ECT was di scontinued without ta peri ng according to th e wishes of th e fa m ily. Sh e remained asymptomatic o n lithium a lone for nearl y two years but is now read m itted for inpatient ECT.
Case 3. Mrs. C is a 72-year-o ld, hospitalized fo ur tim es wit h u n ipola r psychotic depression during th e two yea rs p ri or to maintenance ECT. oteworthy sym p to m s were marked weight loss, terminal inso mnia, agi ta tion, suicidal thoughts, a nd delusional g u ilt. Depression was not fully a llev iated wit h lithium at 9 00 to 1200 m g dail y (se r u m le vel s of 0.7 to 0 .9 meq /I), nor with concurrent d esipramine 100 mg dai ly for three months. Sh e impro ved so mew hat while o n 300 mg tra zodone daily. During th e third ad mission, she was treated with eight ECT sho wing good response . Sh e was di scharged o n trazod o ne 200 to 300 mg dail y, but rel apsed within one month. Sh e rece ived 10 inpa tie n t ECT with marked impro vement a nd was dis charged o n d esipramine 100 mg and lithium 900 mg dai ly. Outpatient ECT was administered weekl y for two treatments, th en e ve ry other week for two treatments, followed by e ig ht monthl y treatments. Sh e ha s been free of major affective sym ptoms for two years and is now maintained on desipramine and lithium as above.
Ca se 4 . Mr. D, a 76 -year-old co nsidered to have a unipolar affective disorder, suffered the first of a series of recurrent se vere d epressio ns with psychosis at age 60 . Each ep isode was cha rac te r ized b y anergia, poor social interaction, paranoid and somatic delusions, a nd pseudod eme nt ia . Various p harmacotherapeutic regimens were ineffective a nd num e rous r eh ospitalizations oc curred. Mainten ance medications tried included 50 mg ma p ro t iline daily for one month, 900 mg lit hium for three months, amitriptyline 75 mg at bedtime fo r six months, desipramine 50 mg dail y fo r o ne m on th , then 75 mg for three weeks, foll ow ed by nortriptylin e 5 0 mg daily for th ree wee ks and 75 mg for one month ; us ually in combination with low d o se thiorida zin e. A co urse of inpatient ECT was markedly effecti ve at age 70 , but he was th en returned to maintenance medication. He remained ch ro n ica lly sym ptoma tic with d e p ressio n but was not rehosp ita lized unti l age 74 . Remi ssion was o b ta ined with a course of ECT. Thereafter, maintenance was achieved with weekl y o u tpa tient ECT for two months, then e very two weeks for two months. He has since (for one and a half yea rs) r emained in remission on nortriptyline 50 to 7 5 mg da ily and thioridazine 25 mg twice dail y.
Maintenance ECT Discontinued Against Advice
Case 5. Mrs. E is a 59-year-old with a 23 yea r history of unipola r affective disorder with multiple e pisod es of melancholic d epression res ponsive to inpatient ECT. In addition to extreme dysphoria , she would report total a n hedonia, insomnia, and intense exacerbation of her ch ro n ic back pain . Imipra m ine 50 mg, protriptylin e 10 mg, amoxapine 50 mg, trazodon e 300 m g , and phe nel zine 30 mg daily, each failed to prolong remission for more th an th ree mo n ths. During the two year s before maintenance ECT was begu n , th e pat ie n t was hospitalized on six occasions for a course of nine inpatient ECT. Fo llowing the last of these episodes, maintenance ECT was administered weekl y fo r two weeks, then every two weeks for three months. In r esponse to increasin g d epressive symptoms the frequency of treatment was increased to thrice weekl y fo r th ree weeks, and remission was obtained. However, she then refu sed fu rt her maintenance ECT, citin g concern regarding possible "brain damage. " No fu rther antidepressant medication was prescribed, and relapse occurred six mo nths later. Since di scontinuation of maintenance ECT, sh e has been ad m itted twic e for inpatient ECT. For the past year remission has be en sustained with trazodone 250 mg daily. No signs of cognitive impairment are ev iden t.
Case 5 . Miss F is a 33-year-old with a 10 yea r history of a bipolar affective disorder. Manic episodes have always responded to neuroleptics an d lithi u m . However, depressive episodes, with consist ent sui cidal ideation , have been refractory to lithium at 900 to 1200 mg daily (serum levels of 0.7 to 0.9 meq /I) to concurrent desipramine 100 mg daily for three months, and to treatmen t with concurrent tran ylcypromine at 30 to 90 mg daily for se ve ra l months. During the two yea r period prior to maintenance ECT, she was hospitaliz ed fou r tim es: three times for depression and once for mania. Inpatient ECT was necessar y once during the year following initiation of a regimen of maintenan ce ECT (weekly, every two weeks, then monthl y). She then moved o u t of sta te, where maintenance has been attempted with various pharmacotherapeutic regi me ns but not ECT. She has been hospitalized three times for depression since the discontinuation of maintenance ECT.
Case 7. Mrs. G, a 53-year-old, co nsid e red to ha ve a bipola r affec ti ve disorder, was first hospitalized for mania at age 58. The mania responded well to lithium, and she remained in remission for two years. During th e two year period prior to maintenance ECT she was admitted three times for psycho tic depression, characterized b y insomnia, anorexia, agitation, obsessive behavio r , and paranoid delusions. Each time she responded to a co u rse o f 12 ECT wit hou t antidepressant medication . An outpatient trial of imipramine 150 mg d ail y for one year did not prevent recurrence of depression . Weekly o u tpa tient ECT alone provided adequate maintenance for two months. Sh e bega n to miss scheduled treatments possibly due to inadequate th erapy. Sh e ra pid ly deteriorated and was readmitted, but ECT was refused. A co m b inatio n of nortriptyline 75 mg and thioridazine 75 mg daily for six weeks was ineffect ive a nd she continued to refuse ECT. She was transferred to a psychiat r ic nursing home where she continues to be severely depressed. Sh e refuses furth er ECT. The famil y does not wish to have the patient adjudicated for in volunta r y trea tmen t.
Maintenance ECT Discontinued by Intercurrent Illnes s and Death
Case 8 . Mrs. H, a 68-year-old co nsid e red to have a b ipo la r affecti ve disorder, was initially diagnosed with " d e p ressive ps ychosis" at age 27. Subsequently, four manic episodes were responsi ve to lithium . Sh e a lso su ffered from severe chronic obstructive lung dis ease. She was hospitalized fou r ti mes for . ps ychotic depression during th e two years prior to maintenance ECT. Symptoms included anergia, anhedonia, insomnia, delusional guilt, a nd visua l ha llucinations. These episodes proved refractory to treatment wit h 150 mg imi p ra m ine daily for three year s (serum level 168 to 231 ng/ml) and p rotriptyline 20 mg dail y for three months, ea ch in co nj u nctio n with lithium , but th en responded to inpatient ECT. She remained euthymic while rec eiving a co u rse of 10 weekly outpatient ECT. Then a full depressive relapse occurred co inci den t with a pneumonia superimposed on her lung dis ease . She di ed be fore m ore frequent ECT could be reinstituted.
DISCUSSION
The ca ses reviewed illustrate how ECT ca n be used as part o f a maintenance strategy in preventing relapse of depression in patients wit h major affective disorder. As a crude measure of e ffective ness, 30 hospitali zati o ns for depression occurred during the two yea r s prior to initiation of ECT for the selected group of patients, compared with 10 hospitalizations durin g t he t wo year post-maintenance ECT period. Actually, only three of the r elapse hosp italizations occurred in patients being actively treated with maintenan ce ECT, t he other seven occurred in those who either refused further ECT or were n o lo n ge r in treatment at our clinic.
In our experience, different patients req u ire d different fre q uency and duration of treatment. Of eight patients, one ap pea red to r equire chronic maintenance therapy, while three were treated on a temporar y basis and the n remained in extended remission whil e not receiving maintenan ce ECT. T he long-term use of ECT is not uniformly well-rec eiv ed, and three patie nts refused further maintenance ECT despite its apparent e ffec tive ness. On th e whole, families seemed to accept continued ECT quite well. The o ne d eath in our review did not appear in any way related to ECT.
It should be noted that all patients studied had a his tory of profound depressive episodes, often with melancholic or ps ychotic features. Four of the eight suffered from bipolar disorders. Previous depressions in th ese patients were responsive to inpatient ECT, but were generally refractory to pharmacotherapy. Such factors may predict which patients ma y best ben e fit from maintenance ECT. However, extensive further research will be necessary to establish a definitive protocol for determining which patients would ben e fit most.
The current report must be viewed as tentative support for th e efficacy o f maintenance ECT. It is a summary of clinical e xpe r ience rat her than a rigorously designed experimental study. Maintenance ECT reg imens we re no t standardized, but were determined by the judgment of a number of clinicians. The possible effectiveness of maintenance ECT cannot be isolated from t he confounding effects of various concurrent psychotropic medications. Anecdotal reports must always be interpreted cautiously, but until more d efinitive st ud ies are available, this report does suggest another strategy in managing certain difficult cases.
Given these limitations, clinicians are encouraged to co nsider mainte na nce ECT in certain affective disorder patients who frequentl y relapse d espite maintenance with medication. Rather than a drastic measure, maintenance ECT is probably safer, less expensive, and less disruptive than un successful maintenance with medication, relapse, and repeated rehospitalizations. Sel ecti on of a maintenance ECT strategy should not lead to unnecessary intensit y of treatment. As with medications, the "dosage" of maintenance ECT ca n be adj us ted relative to the recurrence of symptoms. It is expected that few patie nts will require maintenance ECT on a chronic basis, with a return to mainte nance with medications in most.
